Loading chat...
DE HB21
Bill
Status
Passed
7/21/2025
Primary Sponsor
Kimberly Williams
Click for details
AI Summary
-
Classifies tianeptine as a Schedule I controlled substance in Delaware, including all its salts, isomers, and preparations containing any quantity of the drug
-
Prohibits the manufacturing, selling, or delivery of tianeptine, with violations subject to existing controlled substance penalties under Chapter 47
-
Creates an exception that prevents civil or criminal penalties from being imposed for simple possession of tianeptine by individuals
-
Protects individuals from criminal or civil asset forfeiture for tianeptine possession
Legislative Description
An Act To Amend Title 16 Of The Delaware Code Relating To Tianeptine.
Last Action
Signed by Governor
7/21/2025
Committee Referrals
Health & Social Services3/20/2025
Health & Human Development12/19/2024
Full Bill Text
No bill text available